Aerpio Pharmaceuticals, Inc.
METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2

Last updated:

Abstract:

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.

Status:
Application
Type:

Utility

Filling date:

15 Jan 2021

Issue date:

16 Dec 2021